These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 30608062)

  • 21. The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI).
    Sun Y; Jia X; Gao Q; Liu X; Hou L
    IUBMB Life; 2017 Jan; 69(1):16-21. PubMed ID: 27862841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRIM11, a new target of p53, facilitates the migration and invasion of nasopharyngeal carcinoma cells.
    Zhao Z; Deng J; Lu M; Yang J; Chen L; Li D; Sang Y
    Mol Biol Rep; 2023 Jan; 50(1):731-737. PubMed ID: 36376537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capn4 expression is modulated by microRNA-520b and exerts an oncogenic role in prostate cancer cells by promoting Wnt/β-catenin signaling.
    Ren W; Wang D; Li C; Shu T; Zhang W; Fu X
    Biomed Pharmacother; 2018 Dec; 108():467-475. PubMed ID: 30241050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. microRNA-205 and microRNA-338-3p Reduces Cell Apoptosis in Prostate Carcinoma Tissue and LNCaP Prostate Carcinoma Cells by Directly Targeting the B-Cell Lymphoma 2 (Bcl-2) Gene.
    Zhang X; Pan Y; Fu H; Zhang J
    Med Sci Monit; 2019 Feb; 25():1122-1132. PubMed ID: 30741252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRIM11 stimulates the proliferation of gastric cancer through targeting CPEB3/EGFR axis.
    Luo N; Wang Z
    J BUON; 2020; 25(4):2097-2104. PubMed ID: 33099959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer.
    Katz B; Reis ST; Viana NI; Morais DR; Moura CM; Dip N; Silva IA; Iscaife A; Srougi M; Leite KR
    PLoS One; 2014; 9(11):e113700. PubMed ID: 25409297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRIM11 promotes lymphomas by activating the β-catenin signaling and Axin1 ubiquitination degradation.
    Hou Y; Ding M; Wang C; Yang X; Ye T; Yu H
    Exp Cell Res; 2020 Feb; 387(2):111750. PubMed ID: 31786079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells.
    Mao Y; Chen H; Lin Y; Xu X; Hu Z; Zhu Y; Wu J; Xu X; Zheng X; Xie L
    Oncol Rep; 2013 Jul; 30(1):327-33. PubMed ID: 23670210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
    Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
    Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
    Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
    J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-103 suppresses tumor cell proliferation by targeting PDCD10 in prostate cancer.
    Fu X; Zhang W; Su Y; Lu L; Wang D; Wang H
    Prostate; 2016 May; 76(6):543-51. PubMed ID: 26771762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-19a promotes the metastasis and EMT through CUL5 in prostate cancer cell line PC3.
    Wang Y; Hu J; Qi G; Wang S; Gao J
    J BUON; 2020; 25(4):2028-2035. PubMed ID: 33099949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of Circular RNA Itchy E3 Ubiquitin Protein Ligase Inhibits Cell Proliferation and Promotes Cell Apoptosis Through Targeting MiR-197 in Prostate Cancer.
    Yuan Y; Chen X; Huang E
    Technol Cancer Res Treat; 2019; 18():1533033819886867. PubMed ID: 31694481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TUG1 promotes the development of prostate cancer by regulating RLIM.
    Guo BH; Zhao Q; Li HY
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1926-1933. PubMed ID: 30915735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-613 represses prostate cancer cell proliferation and invasion through targeting Frizzled7.
    Ren W; Li C; Duan W; Du S; Yang F; Zhou J; Xing J
    Biochem Biophys Res Commun; 2016 Jan; 469(3):633-8. PubMed ID: 26703210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1.
    Rajendiran S; Parwani AV; Hare RJ; Dasgupta S; Roby RK; Vishwanatha JK
    Mol Cancer; 2014 Nov; 13():250. PubMed ID: 25406943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion.
    Tiwari A; Mukherjee B; Hassan MK; Pattanaik N; Jaiswal AM; Dixit M
    BMC Cancer; 2019 Apr; 19(1):346. PubMed ID: 30975102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TRIM11 regulated by m6A modification promotes the progression of cervical cancer by PHLPP1 ubiquitination.
    Zhang P; Tang Y; Zhao J; Yang J; Chen Y; Gong Y; Meng S; Shu C
    Neoplasma; 2023 Oct; 70(5):659-669. PubMed ID: 38053376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High expression of TRIM11 correlates with poor prognosis in patients with hepatocellular carcinoma.
    Chen Y; Li L; Qian X; Ge Y; Xu G
    Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):190-196. PubMed ID: 28065743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of microRNA-500 has anti-cancer effect through its conditional downstream target of TFPI in human prostate cancer.
    Cai B; Chen W; Pan Y; Chen H; Zhang Y; Weng Z; Li Y
    Prostate; 2017 Jul; 77(10):1057-1065. PubMed ID: 28631332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.